A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
West Nile virus (WNV) continues to circulate in the USA and forms a threat to the rest of the Western hemisphere. Since methods for the treatment of WNV infections are not available, there is a need for the development of safe and effective vaccines. Here, we describe the construction of a recombina...
Guardado en:
Autores principales: | Byron E E Martina, Petra van den Doel, Penelope Koraka, Geert van Amerongen, Gunther Spohn, Bart L Haagmans, Lisette B V Provacia, Albert D M E Osterhaus, Guus F Rimmelzwaan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/676a1871368e4c7bad7fb9116614ffe0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Feeding patterns of potential West Nile virus vectors in south-west Spain.
por: Joaquín Muñoz, et al.
Publicado: (2012) -
Ensemble ecological niche modeling of West Nile virus probability in Florida.
por: Sean P Beeman, et al.
Publicado: (2021) -
Epidemiologically significant risk factors of human infection with West Nile virus
por: N.O. Vynograd, et al.
Publicado: (2017) -
STING is required for host defense against neuropathological West Nile virus infection.
por: Kathryn McGuckin Wuertz, et al.
Publicado: (2019) -
Antecedent avian immunity limits tangential transmission of West Nile virus to humans.
por: Jennifer L Kwan, et al.
Publicado: (2012)